 |
市場調查報告書
商品編碼
2039019
曲唑酮市場：依產品類型、劑型、活性成分含量、適應症、通路及地區分類Trazodone Market, By Product Type, By Form, By Strength, By Indication, By Distribution Channel, By Geography |
||||||
預計到 2026 年，曲唑酮市值將達到 6.872 億美元，到 2033 年將達到 9.074 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 4.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 6.872億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 4.10% | 2033年市場規模預測： | 9.074億美元 |
全球曲唑酮市場是醫藥產業的重要組成部分，屬於現代臨床實務中廣泛認可的非典型抗憂鬱症。曲唑酮因其兼具抗憂鬱症和催眠的雙重功效而備受推崇。自1980年代上市以來，它已成為治療多種疾病（包括重度憂鬱症、失眠、焦慮症和慢性疼痛管理）最常用的藥物之一。該藥有多種劑型，包括速釋片和緩釋片，劑量規格有50毫克、100毫克、150毫克和300毫克。
全球精神疾病和睡眠障礙病例的增加，以及人們對精神健康照護污名化的減少，對該行業的發展起到了至關重要的作用。因此，曲唑酮已成為抗憂鬱症領域的領先藥物，為製藥公司提供了穩定的收入來源。這也使其成為大型製藥公司和學名藥生產商的焦點。
市場動態
根據世界衛生組織（WHO）的數據，憂鬱症是全球最常見的疾病，因此對有效抗憂鬱劑的需求日益成長。曲唑酮兼具治療憂鬱症和失眠的雙重功效，使其對同時患有這兩種疾病的患者極具價值。此外，其抗膽鹼能作用較低，使其成為優於其他抗憂鬱症的選擇，而人口老化也預計將推動市場成長。
然而，來自學名藥的激烈競爭是阻礙市場成長的因素。這可能導致藥品價格上漲，並對收入產生負面影響。心律不整和陰莖異常勃起等安全問題也是可能影響市場的因素。專利到期和高昂的核准成本加劇了競爭，同時也增加了開發新劑型的難度。儘管如此，該藥物在纖維肌痛、創傷後壓力症候群（PTSD）和物質使用障礙等仿單標示外用途方面仍有許多應用機會。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數創建了全球 trazodon 市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份關於 trazodon 市場的報告針對的是各種產業相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過對全球特拉佐頓市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 前提
- 簡稱
第2章 市場範圍
- 報告摘要
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 法規環境
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 法規環境
- 主要進展
- 產業趨勢
第4章 全球曲唑酮市場：依產品類型分類，2021-2033年
- 品牌商品
- 非專利的
第5章 全球曲唑酮市場：依劑型分類，2021-2033年
- 速釋片
- 緩釋口服錠劑
第6章 全球曲唑酮市場：依活性成分含量分類，2021-2033年
- 50 mg
- 100 mg
- 150 mg
- 300 mg
第7章 全球曲唑酮市場：依適應症分類，2021-2033年
- 憂鬱症
- 焦慮
- 失眠
- 其他
第8章 全球曲唑酮市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球曲唑酮市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Sandoz
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Angelini Pharma SpA
- The Piramal Group
- Fermion Oy
- Apotex Inc.
- Zydus Lifesciences Ltd.
第11章 分析師建議
- 機會
- 分析師意見
- Coherent Opportunity Map
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Trazodone Market is estimated to be valued at USD 687.2 Mn in 2026 and is expected to reach USD 907.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 687.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.10% | 2033 Value Projection: | USD 907.4 Mn |
The global trazodone market constitutes a significant segment in the pharmaceutical industry based on an atypical antidepressant medication that enjoys wide acceptance in contemporary clinical practice. Trazodone is highly regarded for its two-way effect as an antidepressant and hypnotic agent. Since its introduction into the market in the 1980s, it has become one of the most frequently prescribed drugs for major depressive disorder, insomnia, anxiety disorders, and chronic pain management, among other applications. Different forms of the drug include immediate-release and extended-release tablets available in different dosages of 50 mg, 100 mg, 150 mg, and 300 mg.
The rise in cases of mental disorders and sleep disorders around the globe, combined with the process of de-stigmatization of mental health care, has played an important role in the development of the industry. As such, trazodone has become a key drug within the antidepressant segment, providing manufacturers with a reliable revenue stream. Hence, it is a target of interest for both major pharmaceutical companies and generics makers.
Market Dynamics
The global trazodone market has been fueled by the high incidence rates of depression and anxiety, since according to the World Health Organization, depression is considered the most common source of disability across the globe, thus resulting in an increased demand for effective antidepressants. The dual nature of trazodone, which provides benefits for the treatment of both depression and insomnia, makes it highly useful for individuals suffering from both conditions. The aging population is also expected to fuel growth in the market because trazodone is more favorable when compared with other antidepressants on account of its low anticholinergic burden.
However, some obstacles to growth in the market include heavy competition from generics that can put price pressures on the drugs and negatively impact their revenues. Concerns regarding safety such as heart arrhythmias and priapism could be other considerations that may affect the market. Expired patents and high approval costs have only served to heighten the level of competition while making it difficult to develop a novel formulation. There are, however, plenty of chances to pursue the use of the drug in treating off-label conditions such as fibromyalgia, post-traumatic stress disorder (PTSD), and substance addiction disorders.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global trazodone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Angelini Pharma S.p.A., The Piramal Group, Fermion Oy, Apotex Inc., and Zydus Lifesciences Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global trazodone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global trazodone market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generics
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Immediate Release Tablets
- Extended-Release Oral Tablets
- Strength Insights (Revenue, USD Mn, 2021 - 2033)
- 50 mg
- 100 mg
- 150 mg
- 300 mg
- Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Depression
- Anxiety
- Insomnia
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Sandoz
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Angelini Pharma S.p.A.
- The Piramal Group
- Fermion Oy
- Apotex Inc.
- Zydus Lifesciences Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Trazodone Market, By Product Type
- Global Trazodone Market, By Form
- Global Trazodone Market, By Strength
- Global Trazodone Market, By Indication
- Global Trazodone Market, By Distribution Channel
- Global Trazodone Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Trazodone Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Trazodone Market, By Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Immediate Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Extended-Release Oral Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Trazodone Market, By Strength, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 150 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 300 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Trazodone Market, By Indication, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Insomnia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Trazodone Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Trazodone Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Angelini Pharma S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Piramal Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fermion Oy
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Lifesciences Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
下一代生物療法市場－全球產業規模、佔有率、趨勢、機會和預測：按治療領域、技術、地區和競爭格局分類，2021-2031年醫藥活性成分市場－全球產業規模、佔有率、趨勢、機會、預測：依合成類型、應用、地區和競爭格局分類，2021-2031年
特種活性藥物成分市場分析與預測（至2035年）：依類型、產品、服務、技術、應用、劑型、製程、最終用戶及階段分類
小分子原料藥市場：依生產技術、治療應用和最終用戶分類－2026-2032年全球市場預測活性成分市場：2026-2032年全球市場預測（依分子類型、原料、給藥途徑、產品類型、治療應用及用途分類）活性成分（API）CDMO市場：按分子類型、API類別、生產技術、服務組合、開發階段、治療應用和最終用戶分類的全球預測——2026年至2032年醫藥活性成分微粉化市場：依技術、設備類型、原料種類、配方、粒徑範圍、製程模式及應用分類－2026-2032年全球市場預測
2026-2034年全球活性藥物成分（API）市場規模、佔有率、趨勢和成長分析報告藥品活性成分（API）市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類，並提供2026-2034年的洞察和預測聚多卡醇注射液市場按產品類型、濃度等級、包裝類型、應用、年齡層和最終用戶分類，全球預測，2026-2032年